Insigna
Champaign, US · Founded 2019 · Delaware corporation
Find your way into Insigna
Sign up to see every warm intro you have to Insigna
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Insigna team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BA
Byron Alexandrovich WittenbergNamed on SEC filing
CJ
CheMyong Jay KoNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$8.5M disclosed across 4 rounds · 2019–2025
▶$4MraisedJul 2025 · 2 investors · PharmaceuticalsRule 506(b)
▶$4MraisedJul 2025 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Byron Alexandrovich WittenbergExecutive Officer, Director
- CheMyong Jay KoExecutive Officer, Director
- Amount sold
- $4M
- Minimum investment
- $5K
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedMar 2023 · 7 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedMar 2023 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Byron Alexandrovich WittenbergDirector
- CheMyong Jay KoExecutive Officer
- Amount sold
- $1.2M
- Minimum investment
- $5K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$2MraisedAug 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$2MraisedAug 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Byron Alexandrovich WittenbergDirector
- CheMyong Jay KoExecutive Officer, Director
- Amount sold
- $2M
- Minimum investment
- $5K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$1.4MraisedJun 2019 · 18 investors · PharmaceuticalsRule 506(b)
▶$1.4MraisedJun 2019 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- CheMyong Jay KoExecutive Officer, Director
- Byron Alexandrovich WittenbergExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.4M
- Minimum investment
- $5K
- Sales commissions
- $15K
- Placement agents
- AllVest Co. Ltd. (AVL)
- First sale
- May 2019
- Incorporated
- Corporation, Illinois, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Insigna raised?
- Insigna has disclosed $8.5M raised across 4 rounds.
- Where is Insigna headquartered?
- Insigna is headquartered in Champaign, US.